Chimerix call put ratio 1,100 calls to 1 put as shares rally 11%
Pre-Open Stock Movers:GeoVax Labs, Inc. (NASDAQ:GOVX) 73% HIGHER; gains after the WHO calls monkeypox an emergency.IEA (NASDAQ:IEA) 26% HIGHER; MasTec (NYSE:MTZ) and IEA today...
Investing.com – U.S. stocks were mixed after the close on Monday, as gains in the Oil & Gas, Telecoms and Healthcare sectors led shares higher while losses in the Technology,...
We had a tough day in the market. The market opened sharply lower, rallied back in wedges, rolled over hard, and finished not far off lows for the day. There was a last 15-second...
Thermo Fisher Scientific Inc. (NYSE:TMO) is slated to report fourth-quarter 2018 results, before the market opens on Jan 30. In the last reported quarter, the company delivered a...
Chimerix, Inc. is a biotechnology company. The Company is focused on discovering, developing and commercializing medicines that address unmet medical needs. The Company offers TEMBEXA (brincidofovir) is an antiviral for the treatment of smallpox in all age groups, including infants, and for patients who have difficulty swallowing. The Company's product Imipridones is a cancer therapies, which provides ONC201 for brain and other cancers, ONC206 for central nervous system cancer and ONC212 for pancreatic cancer and leukemia. The Company’s DSTAT is a glycosaminoglycan derivative of heparin, which is a treatment for hematologic malignancies, including newly diagnosed acute myeloid leukemia (AML) in combination with standard chemotherapy.